Millennium Management
TSBX

Millennium Management’s Turnstone Biologics TSBX Stock Holding History

Millennium Management’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,858
Closed -$15.9K – 6333
2025
Q1 		$15.9K Sell
38,858
-34,886
-47% -$14.9K ﹤0.01% 5654
2024
Q4 		$36.5K Sell
73,744
-29,284
-28% -$14.5K ﹤0.01% 5636
2024
Q3 		$57.4K Sell
103,028
-22,829
-18% -$35K ﹤0.01% 5672
2024
Q2 		$330K Buy
+125,857
New +$360K ﹤0.01% 4856
2023
Q4 		– Sell
-19,744
Closed -$77.8K – 6549
2023
Q3 		$77.8K Buy
+19,744
New +$176K ﹤0.01% 5395

Other funds holding TSBX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management's TSBX Position: Q2 2025 in Review

Millennium Management sold out of Turnstone Biologics (TSBX) in Q2 2025, closing a stake of 38,858 shares — an estimated $15.9K sold.

Millennium Management first reported a position in TSBX in Q3 2023 and held it in 5 quarters. The position peaked at $330K in Q2 2024. 23 funds tracked by Wall St. Rank hold TSBX as of Q2 2025.

  • Millennium Management reported no remaining Turnstone Biologics position as of Q2 2025 after selling out during the quarter.
  • Millennium Management sold 38,858 Turnstone Biologics shares in Q2 2025, an estimated $15.9K.
  • Millennium Management first reported a position in Turnstone Biologics in Q3 2023 and held it in 5 quarters.
  • Millennium Management's Turnstone Biologics position peaked at $330K in Q2 2024.
  • 23 funds tracked by Wall St. Rank held Turnstone Biologics as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.